Loomis Sayles & Co. L P Boosts Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Loomis Sayles & Co. L P grew its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 2.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,126,645 shares of the company’s stock after purchasing an additional 24,665 shares during the quarter. Loomis Sayles & Co. L P owned approximately 1.29% of HealthEquity worth $92,216,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HQY. Raymond James Trust N.A. boosted its position in HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after purchasing an additional 132 shares during the period. Truist Financial Corp boosted its holdings in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after buying an additional 188 shares during the period. O Shaughnessy Asset Management LLC grew its stake in HealthEquity by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock valued at $426,000 after buying an additional 197 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in HealthEquity by 7.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock valued at $246,000 after acquiring an additional 198 shares during the period. Finally, Elk River Wealth Management LLC lifted its position in shares of HealthEquity by 0.3% during the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after acquiring an additional 217 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frank Corvino sold 1,247 shares of HealthEquity stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now owns 4,823 shares of the company’s stock, valued at $387,093.98. The trade was a 20.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock valued at $884,517 in the last three months. Company insiders own 2.20% of the company’s stock.

HealthEquity Trading Down 0.4 %

HQY opened at $104.25 on Monday. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $105.73. The stock has a market cap of $9.10 billion, a PE ratio of 86.88, a PEG ratio of 1.63 and a beta of 0.52. The business has a 50 day moving average of $87.74 and a 200-day moving average of $81.95.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. Equities research analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on HQY shares. JMP Securities restated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Wednesday, September 4th. BTIG Research raised their price target on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Barrington Research restated an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $107.23.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.